Media CoverageMay 3, 2024GenomeWeb- BillionToOne Pushing Forward in Cancer Diagnostics With First Data on Response Monitoring TestRead
Media CoverageMay 3, 2024BioWorld MedTech Interview- BillionToOne test reduces need for Rhogam in 40% of Rh-negative pregnanciesRead
Press ReleasesApril 17, 2024BILLIONTOONE MITIGATING RHOGAM(R) SHORTAGE WITH UNITY FETAL RhD™ NON-INVASIVE PRENATAL TESTRead
Media CoverageMarch 19, 2024BillionToOne is recognized by Forbes as one of America’s Best Startup Employers for 2024!Read
Press ReleasesJanuary 2, 2024BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceRead